Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review
Bioengineering · 13.03.2023 · 10 (3) · 355
DOI: 10.3390/bioengineering10030355 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 13.03.2023. Verfasst von Doreen Goh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, NUHS Tower block Level 11, …. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council.
Abstract (Originalsprache)
Articular cartilage defects commonly result from trauma and are associated with significant morbidity. Since cartilage is an avascular, aneural, and alymphatic tissue with a poor intrinsic healing ability, the regeneration of functional hyaline cartilage remains a difficult clinical problem. Mesenchymal stem cells (MSCs) are multipotent cells with multilineage differentiation potential, including the ability to differentiate into chondrocytes. Due to their availability and ease of ex vivo expansion, clinicians are increasingly applying MSCs in the treatment of cartilage lesions. However, despite encouraging pre-clinical and clinical data, inconsistencies in MSC proliferative and chondrogenic potential depending on donor, tissue source, cell subset, culture conditions, and handling techniques remain a key barrier to widespread clinical application of MSC therapy in cartilage regeneration. In this review, we highlight the strategies to manage the heterogeneity of MSCs ex vivo for more effective cartilage repair, including reducing the MSC culture expansion period, and selecting MSCs with higher chondrogenic potential through specific genetic markers, surface markers, and biophysical attributes. The accomplishment of a less heterogeneous population of culture-expanded MSCs may improve the scalability, reproducibility, and standardisation of MSC therapy for clinical application in cartilage regeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, NUHS Tower block Level 11, Singapore 119288, Singapore.
- NUS Tissue Engineering Program, Life Sciences Institute, National University of Singapore, 27 Medical Drive, DSO (Kent Ridge) Building, Level 4, Singapore 11751, Singapore.
- Critical Analytics for Manufacturing Personalised-Medicine, Singapore-MIT Alliance for Research and Technology, Singapore 138602, Singapore.
ORCID-Profile: Doreen Goh
Förderung
- National Medical Research Council
Zitieren
APA
Goh, D., Yang, Y., Lee, E. H., Hui, J. H. P., & Yang, Z. (2023). Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review. Bioengineering, 10(3), 355. https://doi.org/10.3390/bioengineering10030355
Vancouver
Goh D, Yang Y, Lee EH, Hui JHP, Yang Z. Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review. Bioengineering. 2023;10(3):355. doi:10.3390/bioengineering10030355
BibTeX
@article{Goh2023,
author = {Goh, Doreen and Yang, Yanmeng and Lee, Eng Hin and Hui, James Hoi Po and Yang, Zheng},
title = {Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review},
journal = {Bioengineering},
year = {2023},
volume = {10},
number = {3},
pages = {355},
doi = {10.3390/bioengineering10030355}
}
EUVIMED